静脉利多卡因的围手术期应用
本文综述静脉利多卡因(IVL)的药代与药效学特性及其围手术期应用。IVL具有抗炎、阿片节俭、减少术后疼痛与阿片消耗、缩短肠麻痹等效应,腹部手术获益较明确,其他手术类型仍有争议;因证据质量受限,荟萃分析对获益不确定性给出结论。常用剂量下治疗指数高,血药浓度多低于心脏与神经毒性阈值。
要点
- IVL在腹部手术中可减少术后疼痛、阿片消耗并缩短肠麻痹。
- 其他手术类型获益仍有争议,证据质量受不一致性、不精确性限制。
- 常用推荐剂量下血药浓度多低于心脏与神经毒性阈值。
核心结论
- IVL具有抗炎和阿片节俭效应,可减少术后疼痛与阿片消耗并缩短肠麻痹持续时间。
- 腹部手术中获益较明确,其他手术类型仍有争议。
- 因证据不一致、不精确及研究质量限制,荟萃分析认为IVL获益存在不确定性。
- 常用推荐剂量下治疗指数高,血药浓度多低于心脏与神经毒性阈值。
研究设计与样本
- 综述,汇总静脉利多卡因药代动力学与药效学特性及围手术期应用证据。
主要发现
- IVL具有抗炎、阿片节俭、减少术后疼痛与阿片消耗、缩短肠麻痹等效应。
- 额外研究显示IVL具有抗血栓、抗菌和抗肿瘤效应。
- IVL可用于预防丙泊酚注射痛、预防痛觉过敏、术中支气管气管松弛保护支气管反应性及增加全麻深度。
- IVL在体内快速分布并经肝脏代谢。
临床怎么用
- 临床可基于常用推荐剂量下血药浓度多低于心脏与神经毒性阈值的特点,权衡IVL与其他镇痛策略的获益风险。
局限性
- 证据质量受不一致性、不精确性和研究质量限制。
- 其他手术类型的获益仍有争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lidocaine is an amide local anaesthetic initially used intravenously as an antiarrhythmic agent. At some point it was proposed that intravenous lidocaine (IVL) had an analgesic effect that could be potentially beneficial in perioperative settings. Since these preliminary reports, a large body of evidence confirmed that IVL had anti-inflammatory and opiate-sparing effects, a combination of characteristics leading to an array of effects such as a decrease in postoperative pain and opiate consumption, and a reduction in the duration of digestive ileus. Additional studies demonstrated IVL to possess antithrombotic, antimicrobial and antitumoral effects. Beneficial effects of IVL have been characterized in abdominal surgery but remain controversial in other types of surgeries. Because the quality of evidence was limited, due to inconsistency, imprecision and study quality, recent conclusions from meta-analysis pooling together all types of surgery stated the uncertainty about IVL benefits. Additional indications such as the prevention of propofol-induced injection pain, prevention of hyperalgesia, protection against bronchial reactivity by bronchotracheal relaxation during surgery, and the increase in depth of general anaesthesia have since emerged. IVL is rapidly distributed in the body and metabolized by the liver. With the commonly recommended doses, lidocaine's therapeutic index remains very high and the plasma concentrations stay largely below the cardiotoxic and neurotoxic threshold levels, a notion that may be used by clinicians to draw conclusions on the benefit-risk profile of IVL in comparison to other analgesic strategies. The purpose of this review is to address the pharmacokinetic and pharmacodynamic properties of lidocaine in healthy and pathological conditions.
引用
- Beaussier M, Delbos A, Maurice-Szamburski A, et al. Perioperative Use of Intravenous Lidocaine. Drugs. 2018. PMID: 30117019. doi:10.1007/s40265-018-0955-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。